vs

Side-by-side financial comparison of CENTRUS ENERGY CORP (LEU) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $146.2M, roughly 1.5× CENTRUS ENERGY CORP). On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs -3.6%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $-58.0M). Over the past eight quarters, CENTRUS ENERGY CORP's revenue compounded faster (82.9% CAGR vs 43.2%).

Centrus Energy Corp. is an American company that supplies nuclear fuel for use in nuclear power plants and works to develop and deploy centrifuge technology to produce enriched uranium for commercial and government uses, including for national security.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

LEU vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.5× larger
ORGO
$225.6M
$146.2M
LEU
Growing faster (revenue YoY)
ORGO
ORGO
+81.7% gap
ORGO
78.1%
-3.6%
LEU
More free cash flow
ORGO
ORGO
$92.8M more FCF
ORGO
$34.8M
$-58.0M
LEU
Faster 2-yr revenue CAGR
LEU
LEU
Annualised
LEU
82.9%
43.2%
ORGO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LEU
LEU
ORGO
ORGO
Revenue
$146.2M
$225.6M
Net Profit
$43.7M
Gross Margin
23.9%
Operating Margin
8.8%
28.1%
Net Margin
19.4%
Revenue YoY
-3.6%
78.1%
Net Profit YoY
469.5%
EPS (diluted)
$0.52
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LEU
LEU
ORGO
ORGO
Q4 25
$146.2M
$225.6M
Q3 25
$74.9M
$150.9M
Q2 25
$154.5M
$101.0M
Q1 25
$73.1M
$86.7M
Q4 24
$151.6M
$126.7M
Q3 24
$57.7M
$115.2M
Q2 24
$189.0M
$130.2M
Q1 24
$43.7M
$110.0M
Net Profit
LEU
LEU
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$3.9M
$21.6M
Q2 25
$28.9M
$-9.4M
Q1 25
$27.2M
$-18.8M
Q4 24
$7.7M
Q3 24
$-5.0M
$12.3M
Q2 24
$30.6M
$-17.0M
Q1 24
$-6.1M
$-2.1M
Gross Margin
LEU
LEU
ORGO
ORGO
Q4 25
23.9%
Q3 25
-5.7%
Q2 25
34.9%
Q1 25
45.0%
72.6%
Q4 24
40.8%
75.5%
Q3 24
15.4%
76.7%
Q2 24
19.3%
77.6%
Q1 24
9.8%
73.9%
Operating Margin
LEU
LEU
ORGO
ORGO
Q4 25
8.8%
28.1%
Q3 25
-22.2%
13.7%
Q2 25
21.7%
-12.5%
Q1 25
28.0%
-30.9%
Q4 24
29.7%
8.1%
Q3 24
-13.2%
5.4%
Q2 24
11.2%
-10.7%
Q1 24
-24.3%
-3.5%
Net Margin
LEU
LEU
ORGO
ORGO
Q4 25
19.4%
Q3 25
5.2%
14.3%
Q2 25
18.7%
-9.3%
Q1 25
37.2%
-21.7%
Q4 24
6.1%
Q3 24
-8.7%
10.7%
Q2 24
16.2%
-13.1%
Q1 24
-14.0%
-1.9%
EPS (diluted)
LEU
LEU
ORGO
ORGO
Q4 25
$0.52
$0.31
Q3 25
$0.19
$0.11
Q2 25
$1.59
$-0.10
Q1 25
$1.60
$-0.17
Q4 24
$3.26
$0.05
Q3 24
$-0.30
$0.09
Q2 24
$1.89
$-0.13
Q1 24
$-0.38
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LEU
LEU
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$2.0B
$93.7M
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$765.1M
$300.1M
Total Assets
$2.4B
$598.7M
Debt / EquityLower = less leverage
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LEU
LEU
ORGO
ORGO
Q4 25
$2.0B
$93.7M
Q3 25
$1.6B
$63.7M
Q2 25
$833.0M
$73.1M
Q1 25
$653.0M
$110.0M
Q4 24
$671.4M
$135.6M
Q3 24
$194.3M
$94.3M
Q2 24
$227.0M
$89.9M
Q1 24
$209.3M
$88.6M
Total Debt
LEU
LEU
ORGO
ORGO
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$390.0M
Q1 25
$389.5M
Q4 24
$472.5M
Q3 24
$83.5M
$62.3M
Q2 24
$86.5M
$63.8M
Q1 24
$86.5M
$65.2M
Stockholders' Equity
LEU
LEU
ORGO
ORGO
Q4 25
$765.1M
$300.1M
Q3 25
$363.1M
$255.1M
Q2 25
$359.1M
$233.2M
Q1 25
$213.9M
$242.9M
Q4 24
$161.4M
$262.9M
Q3 24
$76.4M
$278.5M
Q2 24
$76.6M
$263.5M
Q1 24
$33.8M
$278.0M
Total Assets
LEU
LEU
ORGO
ORGO
Q4 25
$2.4B
$598.7M
Q3 25
$2.2B
$509.8M
Q2 25
$1.3B
$461.1M
Q1 25
$1.3B
$467.4M
Q4 24
$1.1B
$497.9M
Q3 24
$591.0M
$446.3M
Q2 24
$668.2M
$443.2M
Q1 24
$750.0M
$458.5M
Debt / Equity
LEU
LEU
ORGO
ORGO
Q4 25
1.54×
Q3 25
3.23×
Q2 25
1.09×
Q1 25
1.82×
Q4 24
2.93×
Q3 24
1.09×
0.22×
Q2 24
1.13×
0.24×
Q1 24
2.56×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LEU
LEU
ORGO
ORGO
Operating Cash FlowLast quarter
$-48.4M
$39.4M
Free Cash FlowOCF − Capex
$-58.0M
$34.8M
FCF MarginFCF / Revenue
-39.7%
15.4%
Capex IntensityCapex / Revenue
6.6%
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$31.3M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LEU
LEU
ORGO
ORGO
Q4 25
$-48.4M
$39.4M
Q3 25
$10.1M
$3.1M
Q2 25
$52.8M
$-32.9M
Q1 25
$36.5M
$-19.9M
Q4 24
$57.9M
$10.9M
Q3 24
$-33.2M
$8.7M
Q2 24
$7.0M
$4.7M
Q1 24
$5.3M
$-10.2M
Free Cash Flow
LEU
LEU
ORGO
ORGO
Q4 25
$-58.0M
$34.8M
Q3 25
$5.7M
$844.0K
Q2 25
$49.2M
$-36.5M
Q1 25
$34.4M
$-23.6M
Q4 24
$57.2M
$7.6M
Q3 24
$-34.2M
$6.1M
Q2 24
$6.1M
$2.9M
Q1 24
$3.8M
$-12.4M
FCF Margin
LEU
LEU
ORGO
ORGO
Q4 25
-39.7%
15.4%
Q3 25
7.6%
0.6%
Q2 25
31.8%
-36.1%
Q1 25
47.1%
-27.2%
Q4 24
37.7%
6.0%
Q3 24
-59.3%
5.3%
Q2 24
3.2%
2.2%
Q1 24
8.7%
-11.3%
Capex Intensity
LEU
LEU
ORGO
ORGO
Q4 25
6.6%
2.1%
Q3 25
5.9%
1.5%
Q2 25
2.3%
3.6%
Q1 25
2.9%
4.2%
Q4 24
0.5%
2.7%
Q3 24
1.7%
2.2%
Q2 24
0.5%
1.4%
Q1 24
3.4%
2.0%
Cash Conversion
LEU
LEU
ORGO
ORGO
Q4 25
0.90×
Q3 25
2.59×
0.14×
Q2 25
1.83×
Q1 25
1.34×
Q4 24
1.43×
Q3 24
0.71×
Q2 24
0.23×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LEU
LEU

Separative Work Units$111.0M76%
Services$21.8M15%
Other$13.4M9%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons